MII IG Kerndatensatz-Modul Molekulares Tumorboard
2027.0.0-ballot.1 - Germany

This page is part of the MII Implementation Guide Molecular Tumor Board (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Example MedicationStatement: MTBChemo1MedicationStatement6-2

English

partOf:

status: Completed

medication: Doxorubicin

subject: Kim Musterperson (no stated gender), DoB: 1956-03-14

effective: 2023-05-24

note:

Z6 Carboplatin AUC5 d1, pegliposomales Doxorubicin 30 mg/m2 d1

dosage

timing: Events: 2023-05-24

DoseAndRates

-Dose[x]
*30 mg/m2 (Details: UCUM codemg/m2 = 'mg/m2')